In the FCM group, there were 41 patients with moderate anemia (Hb between 7 g/dl to 9.9 g/dl) and eight patients with severe anemia (Hb between 6 g/dl and 7 g/dl). This evidence concerns the gene GSTM1 and anemia (phenotype).